KIRSTEN OLIVER: Open Payments
NPI 1285310573 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 33 payments from 11 companies in 2025. Trend: 2023 $146 · 2024 $860 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $126 |
| AstraZeneca Pharmaceuticals LP | 1 | $123 |
| Merck Sharp & Dohme LLC | 4 | $76 |
| ABIOMED | 3 | $65 |
| Amgen Inc. | 3 | $44 |
| PFIZER INC. | 2 | $36 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
Products named: LEQVIO, JARDIANCE, WAINUA, VERQUVO, REPATHA, Assure WCD, OPSYNVI, ONPATTRO.
Industry payments across NY — which companies pay providers there.
